How Expanded Reimbursement for Coronary CTA (CCTA) Could Improve Cardiovascular Outcomes

With better access to tools like CCTA and diagnostic tools that leverage CCTA, clinicians can better support their patients in managing overall cardiovascular health, patients will benefit from less invasive care and enhanced quality of life, and health systems could ultimately see reduced costs and streamlined workflows.  The post How Expanded Reimbursement for Coronary CTA…

Read More

Sanofi Extends Respiratory Vaccines Reach With $1.15B Acquisition of Clinical-Stage Vicebio

Sanofi’s Vicebio acquisition brings technology for developing vaccine combinations for multiple pathogens, such as RSV and hMPV. The deal complements an existing partnership with Novavax that encompasses R&D of combination vaccines for Covid-19 and flu. The post Sanofi Extends Respiratory Vaccines Reach With $1.15B Acquisition of Clinical-Stage Vicebio appeared first on MedCity News.

Read More

From Admission to Discharge: How AI Reduces Hospital Length of Stay

Implementing patient flow technology ultimately enhances operational efficiency and improves the overall patient experience, making it essential for healthcare organizations aiming for better outcomes, improved capacity management, and greater financial stability. The post From Admission to Discharge: How AI Reduces Hospital Length of Stay appeared first on MedCity News.

Read More

Recent Trends in GLP-1 Use and Spending in Medicare

Ahead of the Trump administration’s planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicare’s negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMS’s Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being…

Read More